Skip to main content

Published locations for Phase 3 study confirms biosimilarity of PF-05280586 with rituximab

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase 3 study confirms biosimilarity of PF-05280586 with rituximab

User login

  • Reset your password
  • /content/phase-3-study-confirms-biosimilarity-pf-05280586-rituximab
  • /hematologynews/article/190366/lymphoma-plasma-cell-disorders/phase-3-study-confirms-biosimilarity-pf
  • /oncologypractice/article/190366/lymphoma-plasma-cell-disorders/phase-3-study-confirms-biosimilarity
  • /hematologynews/nhlhub/article/190366/lymphoma-plasma-cell-disorders/phase-3-study-confirms
  • /hematology-oncology/article/190366/lymphoma-plasma-cell-disorders/phase-3-study-confirms
  • /b-cell-lymphoma-icymi/article/190366/lymphoma-plasma-cell-disorders/phase-3-study-confirms